Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |